| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/28/2001 | US6280633 For measuring concentration of a gas such as ozone in a gas stream |
| 08/28/2001 | US6280622 System for using ligands in particle separation |
| 08/28/2001 | US6280621 Blood filter cartridge with overflow receiver |
| 08/28/2001 | US6280618 Multiplex flow assays preferably with magnetic particles as solid phase |
| 08/28/2001 | US6280603 Electrochemical noise technique for corrosion |
| 08/28/2001 | US6280590 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
| 08/28/2001 | US6280588 NOx-decomposing electrode and NOx concentration-measuring apparatus |
| 08/28/2001 | US6280586 Measuring device using biological cells or chemical biologically active substances contained in an analyte |
| 08/28/2001 | US6280400 Device and method for separating component of a liquid sample |
| 08/28/2001 | US6279380 Noncombustive method of determining the calorific value of fuel gas |
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2178523C Plasma separation filter, plasma separation method using the same and plasma separation apparatus |
| 08/28/2001 | CA2111845C Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 08/28/2001 | CA2107552C Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/28/2001 | CA2054702C Analytical apparatus |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/25/2001 | CA2337562A1 Diagnostics based on tetrazolium compounds |
| 08/23/2001 | WO2001061360A2 Identification of modulators of gpr31 activity |
| 08/23/2001 | WO2001061359A2 Identification of modulators of gpr41 or gpr42 activity |
| 08/23/2001 | WO2001061358A1 A method of assessing the biological status of pathology in epithelial tissue, especially colon |
| 08/23/2001 | WO2001061357A2 Method and apparatus for detection of microscopic pathogens |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061355A1 Molecular impriniting compositions and methods for binding and analyzing macromolecules |
| 08/23/2001 | WO2001061354A1 Compositions and methods for surface imprinting |
| 08/23/2001 | WO2001061353A1 Method of detecting subject to be analyzed |
| 08/23/2001 | WO2001061352A2 Production of a protein biosensor with a defined binding matrix |
| 08/23/2001 | WO2001061351A1 Method for quantitatively detecting antigen |
| 08/23/2001 | WO2001061350A1 Methods and compositions for identifying ligands for nuclear receptors |
| 08/23/2001 | WO2001061349A1 Detection of microbial deposition and immune response at the basement membrane |
| 08/23/2001 | WO2001061348A1 Single target counting assays using semiconductor nanocrystals |
| 08/23/2001 | WO2001061347A1 Urine collection cup |
| 08/23/2001 | WO2001061345A1 Nucleation and crystallization of polymers |
| 08/23/2001 | WO2001061344A1 Computationally targeted evolutionary design |
| 08/23/2001 | WO2001061343A1 Method for examination of feces occult blood |
| 08/23/2001 | WO2001061342A1 Inspection chip for sensor measuring instrument |
| 08/23/2001 | WO2001061341A1 Measuring system |
| 08/23/2001 | WO2001061339A1 Method and apparatus for the debris particulate characterization in lubricants |
| 08/23/2001 | WO2001061329A2 Method for isolating a proportion of a fluid mixture |
| 08/23/2001 | WO2001061325A2 Biochemical blocking layer for liquid crystal assay |
| 08/23/2001 | WO2001061314A1 Method of controlling the flow in a flow system |
| 08/23/2001 | WO2001061310A1 A system for biological specimen preparation |
| 08/23/2001 | WO2001061305A2 Immunoassays detecting or making use of at least two rubber latexallergens |
| 08/23/2001 | WO2001061285A1 Device for measuring mass flow and energy content |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061053A2 Protein and peptide sensors using electrical detection methods |
| 08/23/2001 | WO2001061051A1 Methods for peptide-based cdna characterization and analysis |
| 08/23/2001 | WO2001061050A2 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 08/23/2001 | WO2001061048A2 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 08/23/2001 | WO2001061044A1 Data analysis and display system for ligation-based dna sequencing |
| 08/23/2001 | WO2001061042A2 Composite membranes for assaying biomolecules |
| 08/23/2001 | WO2001061041A2 Multiple-site reaction device and method |
| 08/23/2001 | WO2001061040A1 Microarray methods utilizing semiconductor nanocrystals |
| 08/23/2001 | WO2001061039A2 5-hydroxytryptamine transporter gene polymorphisms |
| 08/23/2001 | WO2001061037A1 Methods and kits for proximity probing |
| 08/23/2001 | WO2001061032A1 Immunoassay and diagnostic reagent for malaria |
| 08/23/2001 | WO2001061031A2 Improved assay for protein tyrosine phosphatases |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060995A1 Cell fusion assays using fluorescence resonance energy transfer |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060984A1 Immortalized vascular adventitial cell line |
| 08/23/2001 | WO2001060982A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060968A1 Devices for motile sperm separation |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060812A1 Dioxin derivatives and method of measurement therewith |
| 08/23/2001 | WO2001060769A1 Segment synthesis |
| 08/23/2001 | WO2001060718A2 Bulk materials management apparatus and method |
| 08/23/2001 | WO2001060517A2 Container for nucleic acid analysis |
| 08/23/2001 | WO2001060408A2 Microcompetiton and human disease |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060355A1 Modulation of bone formation |
| 08/23/2001 | WO2001060350A2 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 08/23/2001 | WO2001060246A2 Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| 08/23/2001 | WO2001060174A2 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | WO2001025793A3 Diagnosis of coeliac disease using a gliadin epitope |
| 08/23/2001 | WO2001023412A3 Methods of screening for agents which inhibit aggregation of polypeptides |
| 08/23/2001 | WO2001023082A3 Biomolecular attachment sites on microelectronic arrays |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001013115A3 Method and device for identifying a biopolymer sequence on a solid surface |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001007479A3 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 08/23/2001 | WO2001006016A3 Amplification of nucleic acids with electronic detection |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000071742A3 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
| 08/23/2001 | WO2000050900A3 Methods and compositions for diagnosing carcinomas |
| 08/23/2001 | WO2000042166A3 Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein |
| 08/23/2001 | WO2000038662A3 The manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | WO1999064625A3 Methods and kits for discovery of rna-binding compounds |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016682 Signal processing for measurement of physiological analytes |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |